- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04497714
Identifying Ultrasonic Diagnostic Characteristics of Cervical Lymphadenopathy: A Retrospective, Multicenter Study
August 2, 2020 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
The observed indexes of the four cervical lymph node diseases were identified by informatics methods, and the differences in the diagnosis of the four diseases were evaluated, so as to improve the clinical diagnosis rate and provide a research basis for the ultrasonic evaluation of the surgical indications of cervical lymph node diseases in the future.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 0571
- Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with one of these four diseases
Description
Inclusion Criteria:
- Patients with one of these four diseases
Exclusion Criteria:
- 1. Patients with severe heart and brain diseases and poor coagulation function. 2. Undiagnosed patients are not included in the statistical analysis. 3. Image distortion of CEUS acquisition cannot be analyzed.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cervical lymph nodes tuberculosis
The patients with Cervical lymph nodes tuberculosis
|
Ultrasonic image collection,consist of three static images and one dynamic image
|
Cervical lymphoma
The patients with
|
Ultrasonic image collection,consist of three static images and one dynamic image
|
Cervical lymph node metastasis
The patients with
|
Ultrasonic image collection,consist of three static images and one dynamic image
|
Cervical Reactive hyperplasia
The patients with
|
Ultrasonic image collection,consist of three static images and one dynamic image
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cervical lymph nodes tuberculosis
Time Frame: through study completion, an average of 1 year
|
It was identified as cervical lymph node tuberculosis by imaging observation
|
through study completion, an average of 1 year
|
Cervical lymphoma
Time Frame: through study completion, an average of 1 year
|
It was identified as cervical lymphoma by imaging observation
|
through study completion, an average of 1 year
|
Cervical lymph node metastasis
Time Frame: through study completion, an average of 1 year
|
It was identified as Cervical lymph node metastasis by imaging observation
|
through study completion, an average of 1 year
|
Cervical Reactive hyperplasia
Time Frame: through study completion, an average of 1 year
|
It was identified as Cervical Reactive hyperplasia by imaging observation
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2017
Primary Completion (ACTUAL)
January 1, 2020
Study Completion (ACTUAL)
January 1, 2020
Study Registration Dates
First Submitted
July 27, 2020
First Submitted That Met QC Criteria
August 2, 2020
First Posted (ACTUAL)
August 4, 2020
Study Record Updates
Last Update Posted (ACTUAL)
August 4, 2020
Last Update Submitted That Met QC Criteria
August 2, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 研2020-539
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
individual participant data(IPD) can be shared after the main unit publish articles
IPD Sharing Time Frame
by request
IPD Sharing Access Criteria
by request
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lymph Node Disease
-
Shanghai Chest HospitalUnknown
-
University of PennsylvaniaFood and Drug Administration (FDA); EUSA Pharma, Inc.; Castleman Disease Collaborative...RecruitingCastleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Hyperplasia, Giant Lymph Node | Lymph Node Hyperplasia, GiantUnited States
-
Centre Hospitalier Universitaire, AmiensCompletedLymph Node Disease | Transbronchial SurgeryFrance
-
Castleman Disease Collaborative NetworkWithdrawnHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Giant Lymph NodeUnited States
-
Jiayuan SunRecruitingLymph Node DiseaseChina
-
Ottawa Hospital Research InstituteTerminatedLymph Node DiseaseCanada
-
Massachusetts General HospitalBrigham and Women's Hospital; Society of University SurgeonsRecruiting
-
Federation of Breast Diseases SocietiesUnknown
-
TakedaCompleted
Clinical Trials on Ultrasonic image collection
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Not yet recruitingBreast Cancer | Axillary Lymph Node Metastasis
-
Technische Universität DresdenUniversity of Leipzig; University Hospital DresdenNot yet recruitingLiver Diseases | Ultrasonography | Artificial Intelligence | Elasticity Imaging Techniques | Metastasis to Liver
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingPancreatic CancerUnited States
-
Brock UniversityDr. Peter C. Fritz, Periodontal Wellness & Implant SurgeryCompletedPeriodontitis | Periodontal PocketCanada
-
Second Affiliated Hospital, School of Medicine,...Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; First Affiliated Hospital of Wenzhou Medical UniversityUnknownRenal Insufficiency | Renal TransplantationChina
-
Universidad de GranadaCompleted
-
Ethicon Endo-SurgeryChildren's Hospital Medical Center, CincinnatiTerminated
-
ZetrOZ, Inc.State University of New York - Upstate Medical UniversityTerminated
-
Tianjin Third Central HospitalBGI, ChinaRecruitingHepatocellular CarcinomaChina
-
University of OsloRecruiting